John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$254M |
| 2 |
Bank of America
BAC
|
+$228M |
| 3 |
KLA
KLAC
|
+$205M |
| 4 |
TSMC
TSM
|
+$191M |
| 5 |
CVS Health
CVS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Goldman Sachs
GS
|
+$237M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
PayPal
PYPL
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.66% |
| 3 | Financials | 12.92% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
PUT
Rivian
RIVN
$24.6B
| $44M | 0.1% |
3,923,600
+130,600
| +3% | +$1.88M |
|
252
Vanguard Information Technology ETF
VGT
$145B
| $43.8M | 0.1% |
597,600
+584,800
| +4,569% | +$41.6M |
|
253
Tradeweb Markets
TW
$22.6B
| $43.8M | 0.1% |
353,947
-41,758
| -11% | -$4.73M |
|
254
CarMax
KMX
$8.82B
| $43.6M | 0.1% |
562,964
-214,780
| -28% | -$17M |
|
255
Aecom
ACM
$8.34B
| $43.6M | 0.1% |
421,787
-74,035
| -15% | -$6.95M |
|
256
West Pharmaceutical
WST
$24.8B
| $43.4M | 0.1% |
144,720
+62,337
| +76% | +$19.1M |
|
257
Axalta
AXTA
$7.75B
| $43.4M | 0.1% |
1,198,962
+169,870
| +17% | +$5.96M |
|
258
Ovintiv
OVV
$18.5B
| $43.3M | 0.09% |
1,130,294
-400,677
| -26% | -$17.3M |
|
259
iShares Russell 1000 ETF
IWB
$49.3B
| $43.2M | 0.09% |
137,400
-109,200
| -44% | -$33.1M |
|
260
Ferrari
RACE
$76.7B
| $42.7M | 0.09% |
90,928
-57,625
| -39% | -$25.8M |
|
261
Duolingo
DUOL
$6.84B
| $42.4M | 0.09% |
150,482
+29,141
| +24% | +$5.98M |
|
262
PUT
Semtech
SMTC
$11.6B
| $42.1M | 0.09% |
921,600
-250,000
| -21% | -$9.2M |
|
263
Ultragenyx Pharmaceutical
RARE
$2.55B
| $42M | 0.09% |
755,683
+187,374
| +33% | +$9.54M |
|
264
Entergy
ETR
$48.8B
| $42M | 0.09% |
637,834
-409,924
| -39% | -$24.2M |
|
265
Moderna
MRNA
$57.9B
| $41.9M | 0.09% |
627,482
+608,105
| +3,138% | +$55.8M |
|
266
Dover
DOV
$27.2B
| $41.7M | 0.09% |
217,600
+112,900
| +108% | +$20.6M |
|
267
Jacobs Solutions
J
$17.6B
| $41.5M | 0.09% |
320,574
-91,009
| -22% | -$11M |
|
268
Unum
UNM
$13.9B
| $41.5M | 0.09% |
698,037
+32,111
| +5% | +$1.74M |
|
269
Bank OZK
OZK
$5.39B
| $41.4M | 0.09% |
963,400
+350,596
| +57% | +$14.9M |
|
270
iShares Biotechnology ETF
IBB
$10.7B
| $41.4M | 0.09% |
284,207
-139,200
| -33% | -$20.1M |
|
271
British American Tobacco
BTI
$121B
| $41M | 0.09% |
1,120,801
+335,117
| +43% | +$12M |
|
272
Yum China
YUMC
$16.9B
| $41M | 0.09% |
909,951
-549,159
| -38% | -$18.3M |
|
273
Avery Dennison
AVY
$13.9B
| $40.5M | 0.09% |
183,531
+175,831
| +2,284% | +$38M |
|
|
MRSH
274
Marsh
MRSH
$91.6B
| $40.3M | 0.09% |
180,698
-32,052
| -15% | -$7.11M |
|
275
MetLife
MET
$60B
| $40.3M | 0.09% |
488,018
+7,960
| +2% | +$595K |
|
Similar funds
John Overdeck's Q3 2024 Portfolio in Review
As of Q3 2024, John Overdeck held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
John Overdeck withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Bank of America worth $226M.
- John Overdeck's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
- John Overdeck added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
- John Overdeck's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
- John Overdeck fully exited Intel in Q3 2024, selling an estimated $161M.
- John Overdeck's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
- John Overdeck opened 444 new positions and closed 348 in Q3 2024.
- John Overdeck's portfolio value rose 3.9% quarter-over-quarter to $45.6B.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.